Numerous papers in international management and strategy have addressed international licensing-out as a type of foreign market entry mode. Scholars, however, haven’t paid enough attention to what firm-level factors determine international licensing...
Numerous papers in international management and strategy have addressed international licensing-out as a type of foreign market entry mode. Scholars, however, haven’t paid enough attention to what firm-level factors determine international licensing-out at the firm-level. To fill this theoretical gap, this paper investigates the effect of firm-level international licensing-in experience on international licensing-out in the context of latecomer firms in the early stage of catch-up. Using a panel dataset of 58 Korean pharmaceutical latecomer firms during 2004 to 2017, we conducted panel Poisson regression to test the influences of international licensing-in experience and international licensing-in experience involving external tacit knowledge transfer on latecomer firm’s international licensing-out. The results show that external tacit knowledge transfer by international licensing-in enhances latecomer firm’s international licensing-out while international licensing-in experience reduces it.